000275466 001__ 275466
000275466 005__ 20240229154942.0
000275466 0247_ $$2doi$$a10.1210/clinem/dgad212
000275466 0247_ $$2pmid$$apmid:37066827
000275466 0247_ $$2ISSN$$a0368-1610
000275466 0247_ $$2ISSN$$a0021-972X
000275466 0247_ $$2ISSN$$a1945-7197
000275466 0247_ $$2altmetric$$aaltmetric:146191930
000275466 037__ $$aDKFZ-2023-00776
000275466 041__ $$aEnglish
000275466 082__ $$a610
000275466 1001_ $$0P:(DE-He78)ef3f7c40c2c68936a43baab29d559371$$aMukama, Trasias$$b0$$eFirst author$$udkfz
000275466 245__ $$aIGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all-causes in EPIC - Heidelberg.
000275466 260__ $$aOxford$$bOxford University Press$$c2023
000275466 3367_ $$2DRIVER$$aarticle
000275466 3367_ $$2DataCite$$aOutput Types/Journal article
000275466 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1695131550_15139
000275466 3367_ $$2BibTeX$$aARTICLE
000275466 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000275466 3367_ $$00$$2EndNote$$aJournal Article
000275466 500__ $$a#EA:C020#LA:C020# / 2023 Sep 18;108(10):e1092-e1105
000275466 520__ $$aThe functional status of organs involved in IGF-1 signalling pathways such as the liver influence circulating levels of IGF-1 and hence its relationship with risk of chronic diseases and mortality, yet has received limited attention.To examine the relationship between IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases and all-causes, accounting for liver function.Case-cohort design nested within EPIC-Heidelberg. IGF-1 was measured in 7,461 stored serum samples collected from 1994 to 1998. Median follow-up for incident mortality events: 17.5 years.General community.The case-cohort included a subcohort of 1,810 men and 1,890 women, in addition to 1668 incident cases of cancer (623 breast, 577 prostate, 202 lung and 268 colorectal cancers), and 1428 cases of CVD (707 MIs and 723 strokes) and 2441 cases of death.Higher IGF-1 levels showed direct associations with risks of breast (1.25 95% CI: [1.06-1.47]) and prostate (1.31 [1.09-1.57]) cancers. Restricted cubic splines plots and models including IGF-1 as quintiles revealed a U-shaped relationship between the biomarker and mortality. Both participants with lowest and highest levels of IGF-1 experienced higher hazards of mortality from cancer, cardiovascular diseases and all-causes. The U-shaped form of the relationship persisted but was attenuated in analyses including only participants without any indications of liver dysfunction.This large population-based prospective study showed that both individuals with lowest and highest levels of circulating IGF-1 were at increased risk of deaths from cancer, cardiovascular and all-causes. For individuals with low IGF-1, the excess risks of death were more pronounced among individuals with liver cancer and cirrhosis but were also present among individuals without elevated liver enzymes.
000275466 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000275466 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000275466 650_7 $$2Other$$aIGF-1
000275466 650_7 $$2Other$$acancer
000275466 650_7 $$2Other$$acardiovascular diseases
000275466 650_7 $$2Other$$aliver enzymes
000275466 650_7 $$2Other$$aliver function
000275466 650_7 $$2Other$$amortality
000275466 7001_ $$aSrour, Bernard$$b1
000275466 7001_ $$0P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aJohnson, Theron$$b2$$udkfz
000275466 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, Verena$$b3$$udkfz
000275466 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b4$$eLast author$$udkfz
000275466 773__ $$0PERI:(DE-600)2026217-6$$a10.1210/clinem/dgad212$$gp. dgad212$$n10$$pe1092-e1105$$tThe journal of clinical endocrinology & metabolism$$v108$$x0368-1610$$y2023
000275466 909CO $$ooai:inrepo02.dkfz.de:275466$$pVDB
000275466 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ef3f7c40c2c68936a43baab29d559371$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000275466 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000275466 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000275466 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000275466 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000275466 9141_ $$y2023
000275466 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-17
000275466 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-17
000275466 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-17
000275466 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-08-24$$wger
000275466 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ CLIN ENDOCR METAB : 2022$$d2023-08-24
000275466 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-24
000275466 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-24
000275466 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-24
000275466 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-24
000275466 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-24
000275466 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-24
000275466 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-08-24
000275466 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-24
000275466 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ CLIN ENDOCR METAB : 2022$$d2023-08-24
000275466 9202_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000275466 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000275466 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000275466 980__ $$ajournal
000275466 980__ $$aVDB
000275466 980__ $$aI:(DE-He78)C020-20160331
000275466 980__ $$aUNRESTRICTED